Gabriel Alan Goldfien, MD
Family Practice · Saint Paul
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
Offices
6 locations · Group Health Inc · 1,627 clinicians in this group
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Goldfien’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A177399 · Delinquent
Licence status: Delinquent · since 2022 · expires 2026-06-30 · University of California San Francisco School of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$1,033
Medicare paid this office $1,033 for 14 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
14 Original Medicare patients in 2024. Average age 78 · Under 65 0% · Health risk score 1.27. Above the middle of the specialty; the typical family practice clinician is at 1.13.
The office billed $3,496, Medicare allowed $1,295 and paid $1,033; for 29 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 14 | 29 | 78 | 1.27 | $3,496 | $1,033 |
| 2023 | 119 | 230 | 77 | 0.99 | $41,581 | $11,920 |
| 2022 | 40 | 572 | 78 | 1.17 | $14,817 | $4,261 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 34 | $3,679 | $108 |
| Short return visit (20+ min) | 41 | $3,138 | $77 |
| Injection of drug or substance under skin or into muscle | 12 | $169 | $14 |
| Automated urinalysis test | 19 | $42 | $2 |
2022: 1 service
| Short return visit (20+ min) | 14 | $1,236 | $88 |
Medicaid work
$285,588 in 2024
Medicaid paid $285,588 for 3,419 billed services this clinician did in 2024, up to 132 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,205 | $268,473 |
| Short return visit (20+ min) | 1,254 | $8,564 |
| Return visit (30+ min) | 857 | $8,376 |
| Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use | 25 | $86 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use | 19 | $35 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 22 | $27 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 19 | $23 |
| Administration of influenza virus vaccine | 18 | $4 |
| 2024 | 3,419 | 8 | 132 | $285,588 |
| 2023 | 3,029 | 5 | 117 | $268,573 |
| 2022 | 432 | 3 | 67 | $45,866 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,234 | $265,322 |
| Short return visit (20+ min) | 1,173 | $2,041 |
| Return visit (30+ min) | 556 | $1,145 |
| Short return visit | 54 | $65 |
| Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | 12 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 214 | $45,795 |
| Short return visit (20+ min) | 161 | $70 |
| Return visit (30+ min) | 57 | $0 |
Drugs they prescribed that Part D paid
$295,066
Pharmacies billed $295,066 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (84 of 2,854) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%. Long-acting opioids: 21% of their opioid prescriptions.
2,481 generic and 345 brand-name prescriptions · $295,066 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 39 | $57,172 | $1,466 |
| Trulicity | 34 | $34,726 | $1,021 |
| Ozempic | 38 | $34,469 | $907 |
| Eliquis | 20 | $16,848 | $842 |
| Basaglar Kwikpen U-100 | 16 | $5,318 | $332 |
See all 64 drugs
| Jardiance | 39 | $57,172 | $1,466 |
| Trulicity | 34 | $34,726 | $1,021 |
| Ozempic | 38 | $34,469 | $907 |
| Eliquis | 20 | $16,848 | $842 |
| Basaglar Kwikpen U-100 | 16 | $5,318 | $332 |
| Buprenorphine-Naloxone | 12 | $3,232 | $269 |
| Fentanyl | 11 | $2,219 | $202 |
| Albuterol Sulfate Hfa | 60 | $1,405 | $23 |
| Atorvastatin | 218 | $1,265 | $6 |
| Isosorbide Dinitrate | 22 | $1,177 | $54 |
| Levothyroxine | 73 | $913 | $13 |
| Gabapentin | 41 | $791 | $19 |
| Diclofenac | 35 | $782 | $22 |
| Tamsulosin | 52 | $734 | $14 |
| Amlodipine Besylate | 177 | $707 | $4 |
| Metformin | 122 | $625 | $5 |
| Omeprazole | 77 | $603 | $8 |
| Lisinopril | 108 | $593 | $5 |
| Metoprolol | 56 | $589 | $11 |
| Losartan | 76 | $548 | $7 |
| Glipizide | 36 | $512 | $14 |
| Olanzapine | 12 | $495 | $41 |
| Pregabalin | 33 | $463 | $14 |
| Fosinopril | 25 | $449 | $18 |
| Clopidogrel | 29 | $436 | $15 |
| Pravastatin | 46 | $404 | $9 |
| Finasteride | 35 | $397 | $11 |
| Rosuvastatin | 28 | $391 | $14 |
| Oxycodone | 21 | $375 | $18 |
| Trazodone | 44 | $349 | $8 |
| Pantoprazole | 25 | $333 | $13 |
| Propranolol | 28 | $319 | $11 |
| Famotidine | 32 | $304 | $10 |
| Baclofen | 29 | $283 | $10 |
| Duloxetine | 16 | $280 | $18 |
| Oxycodone-Acetaminophen | 12 | $275 | $23 |
| Metoprolol | 58 | $272 | $5 |
| Olmesartan Medoxomil | 13 | $260 | $20 |
| Potassium Chloride | 12 | $251 | $21 |
| Fluticasone Propionate | 29 | $239 | $8 |
| Enalapril Maleate | 15 | $219 | $15 |
| Fenofibrate | 18 | $219 | $12 |
| Furosemide | 40 | $218 | $5 |
| Alendronate | 28 | $212 | $8 |
| Hydrocodone-Acetaminophen | 13 | $212 | $16 |
| Oxybutynin Chloride Er | 12 | $211 | $18 |
| Escitalopram | 16 | $211 | $13 |
| Montelukast | 24 | $210 | $9 |
| Oxybutynin Chloride | 21 | $189 | $9 |
| Hydrochlorothiazide | 54 | $179 | $3 |
| Carvedilol | 24 | $174 | $7 |
| Metformin Hcl Er | 27 | $165 | $6 |
| Atenolol | 27 | $154 | $6 |
| Benazepril | 24 | $146 | $6 |
| Spironolactone | 13 | $127 | $10 |
| Hydralazine | 11 | $111 | $10 |
| Triamcinolone Acetonide | 21 | $108 | $5 |
| Zolpidem | 17 | $73 | $4 |
| Simvastatin | 14 | $54 | $4 |
| Sertraline | 15 | $50 | $3 |
| Tramadol | 20 | $48 | $2 |
| Meloxicam | 24 | $38 | $2 |
| Lorazepam | 14 | $31 | $2 |
| Lisinopril-Hydrochlorothiazide | 11 | $22 | $2 |
Year by year
| 2024 | 2,854 | 257 | 3% (84) | 12% | $295,066 |
| 2023 | 1,817 | 304 | 3% (53) | 14% | $227,356 |
| 2022 | 441 | 114 | None | None | $54,561 |
| 2021 | 71 | 25 | None | None | $5,118 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 46 drugs
| Trulicity | 42 | $47,219 | $1,124 |
| Jardiance | 21 | $28,440 | $1,354 |
| Eliquis | 17 | $11,321 | $666 |
| Symbicort | 13 | $9,085 | $699 |
| Atorvastatin | 127 | $2,852 | $22 |
| Amlodipine Besylate | 125 | $1,542 | $12 |
| Levothyroxine | 41 | $1,434 | $35 |
| Diclofenac | 31 | $1,423 | $46 |
| Metformin | 54 | $1,157 | $21 |
| Omeprazole | 47 | $1,093 | $23 |
| Tamsulosin | 33 | $1,028 | $31 |
| Losartan | 47 | $910 | $19 |
| Lisinopril | 56 | $901 | $16 |
| Metoprolol | 26 | $809 | $31 |
| Olmesartan Medoxomil | 11 | $736 | $67 |
| Gabapentin | 28 | $730 | $26 |
| Metoprolol | 45 | $696 | $15 |
| Isosorbide Dinitrate | 14 | $663 | $47 |
| Pregabalin | 21 | $645 | $31 |
| Fluticasone Propionate | 22 | $607 | $28 |
| Trazodone | 42 | $600 | $14 |
| Albuterol Sulfate Hfa | 18 | $574 | $32 |
| Clopidogrel | 24 | $507 | $21 |
| Pravastatin | 16 | $454 | $28 |
| Rosuvastatin | 15 | $401 | $27 |
| Simvastatin | 19 | $396 | $21 |
| Duloxetine | 14 | $372 | $27 |
| Pantoprazole | 17 | $345 | $20 |
| Hydrochlorothiazide | 43 | $345 | $8 |
| Finasteride | 11 | $320 | $29 |
| Fosinopril | 11 | $303 | $28 |
| Baclofen | 16 | $300 | $19 |
| Hydrocodone-Acetaminophen | 15 | $279 | $19 |
| Propranolol | 16 | $276 | $17 |
| Famotidine | 13 | $268 | $21 |
| Olanzapine | 16 | $252 | $16 |
| Glipizide | 19 | $212 | $11 |
| Escitalopram | 13 | $169 | $13 |
| Furosemide | 27 | $163 | $6 |
| Carvedilol | 21 | $161 | $8 |
| Oxycodone-Acetaminophen | 13 | $150 | $12 |
| Ondansetron Odt | 12 | $140 | $12 |
| Ibuprofen | 16 | $114 | $7 |
| Spironolactone | 12 | $112 | $9 |
| Naproxen | 13 | $107 | $8 |
| Latanoprost | 11 | $98 | $9 |
2022: 8 drugs
| Eliquis | 11 | $8,535 | $776 |
| Atorvastatin | 23 | $383 | $17 |
| Amlodipine Besylate | 39 | $362 | $9 |
| Lisinopril | 20 | $226 | $11 |
| Metformin | 14 | $213 | $15 |
| Levothyroxine | 11 | $163 | $15 |
| Gabapentin | 13 | $107 | $8 |
| Alendronate | 12 | $73 | $6 |
Professional record
- NPI
- 1992369805
- Licence
- CA A177399California A177399: Delinquent · expires 2026-06-30
- Trained
- University of California, San Francisco School of Medicine, 2019
- Group
- Group Health Inc
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2019-04-25
- NPI last updated
- 2025-11-14
- NPI record certified
- 2025-11-14
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 795 El Camino Real, Palo Alto, CA, 94301 · 1333 Meridian Ave, San Jose, CA, 95125 · 1642 E Capitol Expy, San Jose, CA, 95121 · 2039 Forest Ave Ste 105, San Jose, CA, 95128 · 455 Oconnor Dr Ste 200, San Jose, CA, 95128